Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: A meta-analysis

1. Cortes, J.
2. Calvo, V.
3. Ramírez-Merino, N.
4. O'shaughnessy, J.
5. Brufsky, A.
6. Robert, N.
7. Vidal, M.
8. Muñoz, E.
9. Perez, J.
10. Dawood, S.
11. Saura, C.
12. Di cosimo, S.
13. González-Martín, A.
14. Bellet, M.
15. Silva, O.E.
16. Miles, D.
17. Llombart, A.
18. Baselga, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDR432 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus